Effectiveness and Safety of Liraglutide in Patients with Weight Regain and Persistence of Type 2 Diabetes Mellitus after Bariatric Surgery

Trial Profile

Effectiveness and Safety of Liraglutide in Patients with Weight Regain and Persistence of Type 2 Diabetes Mellitus after Bariatric Surgery

Completed
Phase of Trial: Phase IV

Latest Information Update: 29 Jul 2015

At a glance

  • Drugs Liraglutide (Primary)
  • Indications Obesity; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Jul 2015 New trial record
    • 09 Jun 2015 Results presented at the 75th Annual Scientific Sessions of the American Diabetes Association.
    • 09 Jun 2015 Primary endpoint has been met. (Change in body weight)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top